Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| (2e)-3-{3-[6-(4-Methyl-1,4-Diazepan-1-Yl)pyrazin-2-Yl]phenyl}prop-2-Enoic Acid | IC50 | 140.0 [1] | |
| N-[(1-Methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine | IC50 | 363.0 [1] | |
| N-[(1-Methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine | Ki | 610.0 [1] | |
| (R,Z)-5-((2-(3-Aminopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)methylene)thiazolidine-2,4-dione | IC50 | 5.0 [1], 150.0 [2] | |
| (R,Z)-5-((2-(3-Aminopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)methylene)thiazolidine-2,4-dione | Ki | 0.16 [1] | |
MLA | "Quest Database™ Serine/threonine-protein kinase PIM2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-pim2-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ Serine/threonine-protein kinase PIM2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-pim2-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |